We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
-8.2%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$462M
AUM Growth
-$51.6M
Cap. Flow
-$441K
Cap. Flow %
-0.1%
Top 10 Hldgs %
15.6%
Holding
395
New
18
Increased
8
Reduced
14
Closed
13

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.31M
2
ABBV icon
AbbVie
ABBV
+$1.95M
3
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$1.27M
4
GERN icon
Geron
GERN
+$1.18M
5
KHC icon
Kraft Heinz
KHC
+$1.16M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.93M
2
AMAG
AMAG Pharmaceuticals
AMAG
+$1.86M
3
AEC
ASSOCIATED ESTATES REALTY CORP
AEC
+$1.72M
4
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$1.3M
5
PLL
PALL CORP
PLL
+$1.25M

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Financials 14.94%
3 Healthcare 14.92%
4 Industrials 11.55%
5 Consumer Staples 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
26
Tenet Healthcare
THC
$20.5B
$3.14M 0.68%
85,000
– –
BNY
27
Bank of New York Mellon
BNY
$106B
$3.13M 0.68%
80,038
– –
UNP icon
28
Union Pacific
UNP
$174B
$3.01M 0.65%
34,000
– –
LLY icon
29
Eli Lilly
LLY
$1.02T
$2.93M 0.63%
35,000
-10,000
-22% -$844K
IBM icon
30
IBM
IBM
$211B
$2.9M 0.63%
20,920
– –
COST icon
31
Costco
COST
$422B
$2.89M 0.63%
20,000
– –
IONS icon
32
Ionis Pharmaceuticals
IONS
$8.6B
$2.83M 0.61%
70,000
– –
VZ icon
33
Verizon
VZ
$195B
$2.83M 0.61%
65,000
– –
CVX icon
34
Chevron
CVX
$392B
$2.76M 0.6%
35,000
– –
AMT icon
35
American Tower
AMT
$80.8B
$2.64M 0.57%
30,000
– –
KO icon
36
Coca-Cola
KO
$377B
$2.61M 0.56%
65,000
– –
GS icon
37
Goldman Sachs
GS
$300B
$2.61M 0.56%
15,000
– –
GOOG icon
38
Alphabet (Google) Class C
GOOG
$4.36T
$2.6M 0.56%
83,300
– –
WMT icon
39
Walmart Inc
WMT
$885B
$2.59M 0.56%
120,000
– –
CMCSK
40
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$2.58M 0.56%
45,000
– –
CL icon
41
Colgate-Palmolive
CL
$73.1B
$2.54M 0.55%
40,000
– –
IDTI
42
DELISTED
Integrated Device Technology I
IDTI
$2.54M 0.55%
125,000
– –
TWX
43
DELISTED
Time Warner Inc
TWX
$2.52M 0.55%
36,666
– –
AWR icon
44
American States Water
AWR
$3.36B
$2.48M 0.54%
60,000
– –
ATVI
45
DELISTED
Activision Blizzard
ATVI
$2.47M 0.53%
80,000
– –
RTX icon
46
RTX Corp
RTX
$290B
$2.23M 0.48%
39,725
– –
PEP icon
47
PepsiCo
PEP
$190B
$2.19M 0.47%
23,251
– –
AET
48
DELISTED
Aetna Inc
AET
$2.19M 0.47%
20,012
+4,000
+25% +$462K
RTN
49
DELISTED
Raytheon Company
RTN
$2.19M 0.47%
20,000
– –
ABBV icon
50
AbbVie
ABBV
$443B
$2.18M 0.47%
40,000
+30,000
+300% +$1.95M
1
2
3 4 5

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q3 2015 Portfolio in Review

As of Q3 2015, NJ State Employees Deferred Compensation Plan held 395 positions worth $462M, down 10% from $514M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

NJ State Employees Deferred Compensation Plan's Q3 2015 filing shows 18 new, 8 increased, 14 reduced and 13 closed positions. Its largest new stake was Biogen: 7,000 shares worth $2.04M. The largest sale was Johnson & Johnson, an estimated $1.93M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • NJ State Employees Deferred Compensation Plan's largest Q3 2015 buy was Biogen: 7,000 shares worth $2.04M.
  • NJ State Employees Deferred Compensation Plan added most to AbbVie in Q3 2015, an estimated $1.95M increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q3 2015 reduction was Johnson & Johnson, cutting an estimated $1.93M.
  • NJ State Employees Deferred Compensation Plan fully exited ASSOCIATED ESTATES REALTY CORP in Q3 2015, selling an estimated $1.72M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 16% of its $462M portfolio in Q3 2015.
  • NJ State Employees Deferred Compensation Plan opened 18 new positions and closed 13 in Q3 2015.
  • NJ State Employees Deferred Compensation Plan's portfolio value fell 10% quarter-over-quarter to $462M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2015, filed 2 Nov 2015.